Episode
Discussing PsA: Risankizumab efficacy across machine learning defined and complex PsA phenotypes
- Podcast
- The IMID Forum
- Published
- Feb 13, 2026
- Duration seconds
- 1250
- Processing state
not_requested- Canonical source
- https://soundcloud.com/imidforum/discussing-psa-risankizumab
Actions
POST https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/discussing-psa-risankizumab-efficacy-across-machine-learning-defined-and-complex-psa-phenotypes/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-imid-forum-981476/discussing-psa-risankizumab-efficacy-across-machine-learning-defined-and-complex-psa-phenotypes.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Join Professor Laura Coates and Phillip Mease as they discuss the top publications in the world of PsA. This month, the conversation covered the ‘classification of patients into distinct PsA phenotypes based on baseline demographics and clinical characteristics using a machine learning approach, and consensus-derived GRAPPA terminology, to support shared clinical decision making, and enable more effective patient stratification in both observational studies and clinical trials.